The new iPad Air perfectly represents what a tablet should be—thin and light, fast enough to run all the must-have apps, yet ...
Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL The combination of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results